迈威生物-U
(688062)
| 流通市值：54.82亿 | | | 总市值：107.29亿 |
| 流通股本：2.04亿 | | | 总股本：4.00亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,564,341,685.47 | 1,695,370,087.4 | 1,722,336,051.32 | 1,650,895,457.76 |
| 应收票据及应收账款 | 28,413,405.38 | 47,100,918.85 | 22,746,899.88 | 17,510,210.05 |
| 应收账款 | 28,413,405.38 | 47,100,918.85 | 22,746,899.88 | 17,510,210.05 |
| 预付款项 | 84,167,759.53 | 35,091,612.44 | 35,014,400.87 | 26,596,108.14 |
| 其他应收款合计 | 41,618,202.64 | 41,380,276.35 | 119,989,871.09 | 112,265,995.71 |
| 存货 | 208,969,757.94 | 173,244,661.06 | 155,668,938.62 | 159,299,441 |
| 其他流动资产 | 68,668,120.94 | 82,271,228.91 | 85,526,796.39 | 66,144,149.01 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,017,126,099.03 | 2,098,846,512.71 | 2,217,103,319.76 | 2,047,592,313.46 |
| 非流动资产: | | | | |
| 长期股权投资 | 44,631,578.72 | 40,647,856.53 | 43,424,300.1 | 41,950,326.49 |
| 固定资产 | 777,421,106.64 | 798,280,341.26 | 603,173,398.06 | 622,789,554.08 |
| 在建工程 | 1,009,848,245.24 | 993,981,820.91 | 1,165,365,122.82 | 1,130,700,157.39 |
| 使用权资产 | 166,747,855.56 | 174,714,499.67 | 175,334,954.99 | 181,562,202.31 |
| 无形资产 | 142,422,801 | 130,315,284.45 | 134,587,710.37 | 139,720,169.43 |
| 商誉 | 118,769,811.89 | 118,769,811.89 | 118,769,811.89 | 118,769,811.89 |
| 长期待摊费用 | 4,510,822.24 | 5,094,287.82 | 433,477.01 | 983,331.14 |
| 其他非流动资产 | 216,110,436.82 | 200,731,886.85 | 183,623,196.15 | 170,980,574.52 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,480,462,658.11 | 2,462,535,789.38 | 2,424,711,971.39 | 2,407,456,127.25 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,497,588,757.14 | 4,561,382,302.09 | 4,641,815,291.15 | 4,455,048,440.71 |
| 流动负债: | | | | |
| 短期借款 | 907,717,127.46 | 771,675,179.24 | 677,188,791.84 | 209,267,627.79 |
| 交易性金融负债 | 3,375,069.1 | 3,375,069.1 | 3,442,098.39 | 3,442,098.39 |
| 应付票据及应付账款 | 88,129,984.91 | 54,498,657.56 | 44,482,987.11 | 62,317,377.83 |
| 应付账款 | 88,129,984.91 | 54,498,657.56 | 44,482,987.11 | 62,317,377.83 |
| 合同负债 | 47,892,292.91 | 21,279,858.1 | 15,079,514.75 | 13,518,550.15 |
| 应付职工薪酬 | 56,220,985 | 51,294,813.43 | 39,831,793.27 | 74,486,423.75 |
| 应交税费 | 24,596,560.7 | 30,550,578.42 | 27,170,858.32 | 31,166,879.69 |
| 其他应付款合计 | 170,160,874 | 195,746,902.66 | 204,627,044.41 | 393,634,236.06 |
| 一年内到期的非流动负债 | 141,427,713.78 | 49,767,691.44 | 39,653,294.8 | 28,553,574.12 |
| 其他流动负债 | 3,565,047.03 | 582,163.92 | - | - |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,443,085,654.89 | 1,178,770,913.87 | 1,051,476,382.89 | 816,386,767.78 |
| 非流动负债: | | | | |
| 长期借款 | 985,798,859.16 | 1,052,741,377.53 | 1,022,315,828.62 | 887,715,828.62 |
| 租赁负债 | 147,169,044.74 | 159,036,369.94 | 158,387,124.49 | 167,105,781.06 |
| 预计负债 | 924,334.32 | 769,944.02 | - | - |
| 递延收益 | 15,639,854.78 | 13,823,000 | 13,932,500 | 10,592,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,149,532,093 | 1,226,370,691.49 | 1,194,635,453.11 | 1,065,413,609.68 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,592,617,747.89 | 2,405,141,605.36 | 2,246,111,836 | 1,881,800,377.46 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 399,600,000 | 399,600,000 | 399,600,000 | 399,600,000 |
| 资本公积 | 5,959,402,817.93 | 5,959,318,670 | 5,959,191,991.49 | 5,930,649,018.13 |
| 其他综合收益 | 3,786,640.68 | 5,370,336.91 | 4,925,414.14 | 4,802,329.54 |
| 未分配利润 | -4,445,439,800.1 | -4,196,331,698.81 | -3,957,007,981.07 | -3,751,349,456.68 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,917,349,658.51 | 2,167,957,308.1 | 2,406,709,424.56 | 2,583,701,890.99 |
| 少数股东权益 | -12,378,649.26 | -11,716,611.37 | -11,005,969.41 | -10,453,827.74 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,904,971,009.25 | 2,156,240,696.73 | 2,395,703,455.15 | 2,573,248,063.25 |
| 负债和股东权益合计 | 4,497,588,757.14 | 4,561,382,302.09 | 4,641,815,291.15 | 4,455,048,440.71 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-30 | 2024-04-09 |
| 审计意见(境内) | | | | 标准无保留意见 |